InvestorsHub Logo
Followers 3
Posts 577
Boards Moderated 0
Alias Born 08/27/2020

Re: None

Monday, 01/08/2024 12:43:14 PM

Monday, January 08, 2024 12:43:14 PM

Post# of 44263
$100 mil, new funds will boost Kriya's technology and expand its pipeline, as well as propel assets in oncology, eye diseases and metabolic diseases

They may like CUBT indications …. As they say .. “ Geographic atrophy is an advanced form of dry age-related macular degeneration and uveitis refers to a group of inflammatory diseases that causes swelling in the eye and destroys eye tissues.”

https://www.fiercebiotech.com/biotech/kriya-grabs-100m-to-bankroll-gene-therapies-for-diabetes-other-prevalent-diseases